Genomic structure and mapping of human FADD, an intracellular mediator of lymphocyte apoptosis, J Immunol, vol.157, pp.5461-5466, 1996. ,
located within the CCND1-EMS1 locus on human chromosome 11q13, encodes the eighttransmembrane protein homologous to C12orf3, C11orf25 and FLJ34272 gene products, Int J Oncol, vol.22, pp.1375-1381, 2003. ,
A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis., Molecular and Cellular Biology, vol.16, issue.6, pp.2756-2763, 1996. ,
DOI : 10.1128/MCB.16.6.2756
FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis, Cell, vol.81, issue.4, pp.505-512, 1995. ,
DOI : 10.1016/0092-8674(95)90071-3
The death domain superfamily: a tale of two interfaces?, Trends in Biochemical Sciences, vol.26, issue.8, pp.475-481, 2001. ,
DOI : 10.1016/S0968-0004(01)01905-3
NMR structure and mutagenesis of the FADD (Mort1) death-effector domain, Nature, vol.392, pp.941-945, 1998. ,
Phosphorylation of FADD/ MORT1 at Serine 194 and Association with a 70-kDa Cell Cycle-Regulated Protein Kinase, The Journal of Immunology, vol.164, issue.3, pp.1236-1242, 2000. ,
DOI : 10.4049/jimmunol.164.3.1236
A Function of Fas-Associated Death Domain Protein in Cell Cycle Progression Localized to a Single Amino Acid at Its C-Terminal Region, Immunity, vol.18, issue.4, pp.513-521, 2003. ,
DOI : 10.1016/S1074-7613(03)00083-9
Molecular evidence for the nuclear localization of FADD, Cell Death and Differentiation, vol.10, issue.7, pp.791-797, 2003. ,
DOI : 10.1038/sj.cdd.4401237
Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: A potential link between genome surveillance and apoptosis, Proceedings of the National Academy of Sciences, vol.276, issue.32, pp.5211-5216, 2003. ,
DOI : 10.1074/jbc.M103838200
FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis, Science, vol.279, issue.5358, pp.1954-1958, 1998. ,
DOI : 10.1126/science.279.5358.1954
Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1, Nature, vol.392, pp.296-300, 1998. ,
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis, Nature, vol.356, issue.6367, pp.314-317, 1992. ,
DOI : 10.1038/356314a0
Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver, Nature Genetics, vol.7, issue.3, pp.294-300, 1995. ,
DOI : 10.1038/ng1195-294
FADD Is Required for DR4- and DR5-mediated Apoptosis: LACK OF TRAIL-INDUCED APOPTOSIS IN FADD-DEFICIENT MOUSE EMBRYONIC FIBROBLASTS, Journal of Biological Chemistry, vol.275, issue.33, pp.25065-25068, 2000. ,
DOI : 10.1074/jbc.C000284200
Apoptosis by Death Factor, Cell, vol.88, issue.3, pp.355-365, 1997. ,
DOI : 10.1016/S0092-8674(00)81874-7
Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8, Journal of Biological Chemistry, vol.276, issue.49, pp.46639-46646, 2001. ,
DOI : 10.1074/jbc.M105102200
Caspase-10 is an initiator caspase in death receptor signaling, Proceedings of the National Academy of Sciences, vol.13, issue.19, pp.13884-13888, 2001. ,
DOI : 10.1101/gad.13.19.2514
Cytotoxicity-dependent APO-1 (Fas/ CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor, Embo J, vol.14, pp.5579-5588, 1995. ,
FLICE, A Novel FADD-Homologous ICE/CED-3???like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex, Cell, vol.85, issue.6, pp.817-827, 1996. ,
DOI : 10.1016/S0092-8674(00)81266-0
Membrane Oligomerization and Cleavage Activates the Caspase-8 (FLICE/MACHalpha 1) Death Signal, Journal of Biological Chemistry, vol.273, issue.8, pp.4345-4349, 1998. ,
DOI : 10.1074/jbc.273.8.4345
The death effector domain protein family: regulators of cellular homeostasis, Nature Immunology, vol.4, issue.5, pp.404-409, 2003. ,
DOI : 10.1038/ni0503-404
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors, Nature, vol.386, issue.6624, pp.517-521, 1997. ,
DOI : 10.1038/386517a0
Inhibition of death receptor signals by cellular FLIP, Nature, vol.388, pp.190-195, 1997. ,
Death-effector Filaments: Novel Cytoplasmic Structures that Recruit Caspases and Trigger Apoptosis, The Journal of Cell Biology, vol.24, issue.5, pp.1243-1253, 1998. ,
DOI : 10.1126/science.275.5303.1129
A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes, The EMBO Journal, vol.17, issue.3, pp.706-718, 1998. ,
DOI : 10.1093/emboj/17.3.706
T cell-specific FADD-deficient mice: FADD is required for early T cell development, Proceedings of the National Academy of Sciences, vol.164, issue.3, pp.6307-6312, 2001. ,
DOI : 10.4049/jimmunol.164.3.1236
FADD/MORT1, a signal transducer that can promote cell death or cell growth, The International Journal of Biochemistry & Cell Biology, vol.31, issue.5, pp.533-537, 1999. ,
DOI : 10.1016/S1357-2725(99)00003-5
Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells, Current Biology, vol.11, issue.4, pp.273-276, 2001. ,
DOI : 10.1016/S0960-9822(01)00067-7
The Requirements for Fas-Associated Death Domain Signaling in Mature T Cell Activation and Survival, The Journal of Immunology, vol.171, issue.1, pp.247-256, 2003. ,
DOI : 10.4049/jimmunol.171.1.247
FADD-deficient T Cells Exhibit a Disaccord in Regulation of the Cell Cycle Machinery, Journal of Biological Chemistry, vol.276, issue.32, pp.29815-29818, 2001. ,
DOI : 10.1074/jbc.M103838200
Cell Cycle Effects by C-FADD Depend on Its C-terminal Phosphorylation Site, Journal of Biological Chemistry, vol.278, issue.43, pp.41585-41588, 2003. ,
DOI : 10.1074/jbc.C300385200
Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis, Carcinogenesis, vol.25, issue.7, pp.1089-1097, 2004. ,
DOI : 10.1093/carcin/bgh130
FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor, The EMBO Journal, vol.180, issue.5, pp.931-941, 2000. ,
DOI : 10.1093/emboj/19.5.931
Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells, Oncogene, vol.22, issue.18, pp.2795-2804, 2003. ,
DOI : 10.1038/sj.onc.1206399
Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice., Proceedings of the National Academy of Sciences, vol.91, issue.22, pp.10488-10492, 1994. ,
DOI : 10.1073/pnas.91.22.10488
Absence or Low Expression of Fas-Associated Protein with Death Domain in Acute Myeloid Leukemia Cells Predicts Resistance to Chemotherapy and Poor Outcome, Cancer Research, vol.64, issue.21, pp.8101-8108, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-2361
Functional expression of Fas (CD95) in acute myeloid leukemia cells in the context of CD34 and CD38 expression: possible correlation with sensitivity to chemotherapy, pp.4901-4909, 1997. ,
Membrane-bound Fas (Apo-1/CD95) ligand on leukemic cells: A mechanism of tumor immune escape in leukemia patients, Blood, vol.94, pp.3135-3140, 1999. ,
Signaling pathways activated by daunorubicin, Blood, vol.98, issue.4, pp.913-924, 2001. ,
DOI : 10.1182/blood.V98.4.913
Cytotoxic drugs and the CD95 pathway, Leukemia, vol.13, issue.11, pp.1854-1858, 1999. ,
DOI : 10.1038/sj.leu.2401333
Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells, Blood, vol.96, pp.3900-3906, 2000. ,
Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL, Nature Medicine, vol.7, issue.6, pp.680-686, 2001. ,
DOI : 10.1038/89050
Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs, Journal of Biological Chemistry, vol.274, issue.12, pp.7987-7992, 1999. ,
DOI : 10.1074/jbc.274.12.7987
Sensitization of Cancer Cells Treated With Cytotoxic Drugs to Fas-Mediated Cytotoxicity, JNCI Journal of the National Cancer Institute, vol.89, issue.11, pp.783-789, 1997. ,
DOI : 10.1093/jnci/89.11.783
Fas ligand expression in nodal non-Hodgkin's lymphoma, Mod Pathol, vol.11, pp.369-375, 1998. ,
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape, Science, vol.274, issue.5291, pp.1363-1366, 1996. ,
DOI : 10.1126/science.274.5291.1363
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?, Journal of Clinical Investigation, vol.99, issue.6, pp.1173-1178, 1997. ,
DOI : 10.1172/JCI119273
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand, Journal of Experimental Medicine, vol.184, issue.3, pp.1075-1082, 1996. ,
DOI : 10.1084/jem.184.3.1075
Lymphocyte apoptosis induced by CD95 (APO???1/Fas) ligand???expressing tumor cells ??? A mechanism of immune evasion?, Nature Medicine, vol.25, issue.12, pp.1361-1366, 1996. ,
DOI : 10.1038/379682a0
Human lung carcinomas express Fas ligand, Cancer Res, vol.57, pp.1007-1012, 1997. ,
Fas Ligand Expression in Thyroid Carcinomas: A Potential Mechanism of Immune Evasion, The Journal of Clinical Endocrinology & Metabolism, vol.84, issue.8, pp.2924-2932, 1999. ,
DOI : 10.1210/jcem.84.8.5917
Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape, Nature Medicine, vol.6, issue.5, pp.493-495, 2000. ,
DOI : 10.1038/74955
Countering the 'counterattack' hypothesis, Nature Medicine, vol.7, issue.3, p.259, 2001. ,
DOI : 10.1038/85357
Cutting Edge: The Tumor Counterattack Hypothesis Revisited: Colon Cancer Cells Do Not Induce T Cell Apoptosis Via the Fas (CD95, APO-1) Pathway, The Journal of Immunology, vol.164, issue.10, pp.5023-5027, 2000. ,
DOI : 10.4049/jimmunol.164.10.5023
Dichotomy between naive and memory CD4+ T cell responses to Fas engagement, Proceedings of the National Academy of Sciences, vol.10, issue.1, pp.8104-8109, 1999. ,
DOI : 10.1006/smim.1997.0102
Fas engagement accelerates liver regeneration after partial hepatectomy, Nat Med, vol.6, pp.920-923, 2000. ,
Fas Signal Transduction Triggers Either Proliferation or Apoptosis in Human Fibroblasts, Journal of Investigative Dermatology, vol.108, issue.2, pp.215-219, 1997. ,
DOI : 10.1111/1523-1747.ep12334273
Fas/APO-1 Expression and Function on Malignant Cells of Hematologic and Nonhematologic Origin, Journal of Immunotherapy, vol.14, issue.3, pp.234-241, 1993. ,
DOI : 10.1097/00002371-199310000-00011
Carboplatin induces Fas (APO-1/CD95)-dependent apoptosis of human tongue carcinoma cells: Sensitization for apoptosis by upregulation of FADD expression, International Journal of Cancer, vol.19, issue.5, pp.593-600, 2003. ,
DOI : 10.1002/ijc.11133
Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes, Cell, vol.114, issue.2, pp.181-190, 2003. ,
DOI : 10.1016/S0092-8674(03)00521-X
URL : https://hal.archives-ouvertes.fr/inserm-00527105